Search

Your search keyword '"Demeret, Sophie"' showing total 441 results

Search Constraints

Start Over You searched for: Author "Demeret, Sophie" Remove constraint Author: "Demeret, Sophie"
441 results on '"Demeret, Sophie"'

Search Results

2. Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life

5. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

7. Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study

8. Clinical features, etiologies, and outcomes in adult patients with meningoencephalitis requiring intensive care (EURECA): an international prospective multicenter cohort study

11. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

12. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

14. Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial

17. Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial

19. Neuro-Psychological Outcome of ICU-Admitted COVID-19 Patients Presenting With CNS Complications

20. Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABA B R Antibodies

26. Clinical features and outcome of patients with primary central nervous system lymphoma admitted to the intensive care unit: a French national expert center experience

27. Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABABR Antibodies

28. Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety

31. Metabolomic changes in adults with status epilepticus: A human case–control study.

37. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

38. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

39. Clinical features, etiologies, and outcomes in adult patients with meningoencephalitis requiring intensive care (EURECA): an international prospective multicenter cohort study

41. Brain Metabolic Alterations in Seropositive Autoimmune Encephalitis: An 18F-FDG PET Study

42. Single-cell mass cytometry on peripheral cells in Myasthenia Gravis identifies dysregulation of innate immune cells

44. Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis Thymus

45. Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells

46. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

47. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

48. Older patients with COVID‐19 and neuropsychiatric conditions: A study of risk factors for mortality

50. Description and Outcome of Severe Hypoglycemic Encephalopathy in the Intensive Care Unit

Catalog

Books, media, physical & digital resources